source
- Flagship Pioneering invests £100 million to launch AI-focused biotech lab in LondonFlagship Pioneering, the life‑science investor behind Moderna, announced the creation of a new laboratory in London. The lab will concentrate on building AI‑native platform companies, using artifi…
- CG Oncology's oncolytic therapy shows positive Phase 3 results in non-muscle invasive bladder cancerCG Oncology announced that its oncolytic immunotherapy, cretostimogene grenadenorepvec, achieved its primary endpoints in a Phase 3 trial involving patients with non-muscle invasive bladder cancer.…